These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29235059)

  • 1. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
    Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
    Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures-results from the ICUROS.
    Svedbom A; Borgstöm F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Kallikorm R; Lember M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Solodovnikov A; Tamulaitiene M; Thomas T; Toroptsova N; Uusküla A; Tosteson ANA; Jönsson B; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):557-566. PubMed ID: 29230511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life after fragility fracture in the Russian Federation: results from the Russian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (ICUROS).
    Lesnyak O; Svedbom A; Belova K; Dobrovolskaya O; Ershova O; Golubev G; Grebenshikov V; Ivanov S; Kochish A; Menshikova L; Nikitinskaya O; Nurligayanov R; Solodovnikov A; Toroptsova N; Varavko J; Zotkin E; Borgstrom F; Kanis JA
    Arch Osteoporos; 2020 Mar; 15(1):37. PubMed ID: 32124066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
    Svedbom A; Borgstöm F; Hernlund E; Alekna V; Bianchi ML; Clark P; Diaz-Curiel M; Dimai HP; Jürisson M; Lesnyak O; McCloskey E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
    Qual Life Res; 2023 Apr; 32(4):1199-1208. PubMed ID: 36495384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)--quality of life during the first 4 months after fracture.
    Borgström F; Lekander I; Ivergård M; Ström O; Svedbom A; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Kallikorm R; Lesnyak O; McCloskey E; Nassonov E; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson AN; Jönsson B; Kanis JA
    Osteoporos Int; 2013 Mar; 24(3):811-23. PubMed ID: 23306819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state utility values and patient-reported outcomes before and after vertebral and non-vertebral fractures in an osteoporosis clinical trial.
    Imai T; Tanaka S; Kawakami K; Miyazaki T; Hagino H; Shiraki M;
    Osteoporos Int; 2017 Jun; 28(6):1893-1901. PubMed ID: 28265719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D.
    Feng Y; Herdman M; van Nooten F; Cleeland C; Parkin D; Ikeda S; Igarashi A; Devlin NJ
    Qual Life Res; 2017 Aug; 26(8):2067-2078. PubMed ID: 28343350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
    Teni FS; Rolfson O; Berg J; Leidl R; Burström K
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
    [No Abstract]   [Full Text] [Related]  

  • 10. Health-related quality of life during the first year after a hip fracture: results of the Mexican arm of the International Cost and Utility Related to Osteoporotic Fractures Study (MexICUROS).
    Guirant L; Carlos F; Curiel D; Kanis JA; Borgström F; Svedbom A; Clark P
    Osteoporos Int; 2018 May; 29(5):1147-1154. PubMed ID: 29464277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
    Stevens K; Brazier J; Rowen D
    Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
    Kiadaliri AA; Eliasson B; Gerdtham UG
    Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential change in quality of life for patients with incident clinical fractures: a prospective study.
    Hagino H; Nakamura T; Fujiwara S; Oeki M; Okano T; Teshima R
    Osteoporos Int; 2009 May; 20(5):695-702. PubMed ID: 18836672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
    Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
    BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of utility index of quality of life (QOL) in prostate cancer patients: comparison of QOL utility index EuroQol-5D (EQ-5D) and visual analogue scale (VAS) with health-related QOL questionnaires SF-36 and EPIC].
    Akakura K; Matsuzaki K; Kobayashi T; Kitoh H; Mizoguchi K; Tomikawa G; Takura T; Kawabuchi K
    Nihon Hinyokika Gakkai Zasshi; 2011 Jan; 102(1):9-13. PubMed ID: 21520631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
    Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
    BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
    Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
    Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life following hip fractures: results from the Norwegian hip fracture register.
    Gjertsen JE; Baste V; Fevang JM; Furnes O; Engesæter LB
    BMC Musculoskelet Disord; 2016 Jul; 17():265. PubMed ID: 27387741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
    Fitriana TS; Roudijk B; Purba FD; Busschbach JJV; Stolk E
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):157-167. PubMed ID: 36348155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.